Quote:I was especially interested in the moment when Dr. NP smiled and suggested they could even present preliminary results to the FDA on the P2 Mild-Moderate next Friday.
I did not understand that was a possibility.
It isn't in my opinion. 0% chance. First, I believe they need two weeks of data from a significant number of enrollees. Second, with only a few enrolled, there's very little chance 30 or 40 is sufficient to reach a strong enough p-value in such a short period of time. Last, they're blinded to the data. Not even sure they'll get to see interim data. Usually the company handling the trial/data is the only one that sees it. Which means the pace of the trial is also dependent upon someone else's timeline.
So to suggest they'll have enough people, enough data, hospitals that perform whatever they need to and a company ready to format, scrub and submit the data to FDA by next week seems far fetched unfortunately.
That aside, this was an excellent webcast once again. The host? Not so much.
